Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis
Next-generation sequencing (NGS) has reached the molecular diagnostic laboratories. Although the NGS technology aims to improve the effectiveness of therapies by selecting the most promising therapy, concerns are that NGS testing is expensive and that the ‘benefits’ are not yet in relation to these...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Cancer Intelligence
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102690/ |